Literature DB >> 8373087

The World Health Organization's revised classification of tumours of the larynx, hypopharynx, and trachea.

A Ferlito1.   

Abstract

A second edition of the Histological Typing of Upper Respiratory Tract Tumours in the WHO series International Histological Classification of Tumours was published in 1991. The new edition has been entitled Histological Typing of Tumours of the Upper Respiratory Tract and Ear. The task of revising the first edition, which was published in 1978, was undertaken at the WHO Center for Upper Respiratory Tract Tumours by K. Shanmugaratnam in collaboration with L. H. Sobin and pathologists in 8 countries. Several tumour types have been added to the classification, and some have been redefined in light of current knowledge. This presentation outlines the changes in the revised WHO classification as regards tumours of the larynx, hypopharynx, and trachea and discusses the grounds for said revisions.

Entities:  

Mesh:

Year:  1993        PMID: 8373087     DOI: 10.1177/000348949310200903

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  3 in total

Review 1.  Oral and Maxillofacial Neuroendocrine Carcinoma: A Systematic Review.

Authors:  Lauren Frenzel Schuch; Tuany Rafaeli Schmidt; Gisele de Oliveira Zigmundo; Laura Borges Kirschnick; Felipe Martins Silveira; Marco Antonio Trevizani Martins; Roman Carlos; Jean Nunes Dos Santos; Felipe Paiva Fonseca; Pablo Agustin Vargas; Vivian Petersen Wagner; Manoela Domingues Martins
Journal:  Head Neck Pathol       Date:  2021-12-06

2.  Neuroendocrine Tumors of the Head and Neck: A Selected Review with Emphasis on Terminology.

Authors:  Stacey E. Mills
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

3.  Survival benefit of adding chemotherapy to intensity modulated radiation in patients with locoregionally advanced nasopharyngeal carcinoma.

Authors:  Xuemei Ji; Conghua Xie; Desheng Hu; Xia Fan; Yajuan Zhou; Yingjie Zheng
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.